Drug Trial Radar · NCT05751928
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma
Last checked: Nov 19, 2026Latest source record: Jul 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
411
Actual
Start
Apr 5, 2023
Primary completion
Jan 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- BiocadIndustry
- Sponsor type
- Industry
- First posted
- Mar 2, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is an open-label, randomized, comparative phase III study, which will include subjects with resectable stage III skin melanoma (up to 3 resectable transient metastases are acceptable).
Conditions
- Melanoma Stage III
- Melanoma (Skin)
Interventions
BCD-217Biological
BCD-217 (anti-CTLA4 agent nurulimab + anti-PD1) once every 3 weeks in the neoadjuvant setting
anti-PD1Biological
anti-PD1 agent in the adjuvant setting
Excision of the primary lesionProcedure
Excision of the primary lesion will be performed per standard of care.
Regional lymphadenectomyProcedure
Regional lymphadenectomy will be performed per standard of care.
Primary outcomes
What the sponsor says the trial is designed to measure.
- event free survival (EFS)Time frame: 24 months
Locations
36 sites in 2 countries. Site status is shown where the registry gives one.
State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov"
Lesnoy, Belarus
Healthcare Institution "Minsk City Clinical Cancer Center"
Minsk, Belarus
State Institution "Mogilev Regional Oncological Dispensary"
Mogilev, Belarus
Healthcare Institution "Vitebsk Regional Clinical Oncology Center"
Vitebsk, Belarus
State Budgetary Healthcare Institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine",
Chelyabinsk, Russia
State budgetary healthcare institution Leningrad Regional Clinical Hospital
Gatchina, Russia
State Autonomous Health Institution "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal"
Kazan', Russia
State budgetary health care institution "Kuzbass clinical oncological dispensary named after M.S. Rappoport"
Kemerovo, Russia
Regional Goverment Budgetary Healthcare State "Kostroma Oncology Center"
Kostroma, Russia
State Budgetary Institution of Healthcare "Leningrad Regional Clinical Oncological Dispensary named after V.I. L.D. Romana"
Kuz'molovskiy, Russia
"Russian Cancer Research Center named after N.N. Blokhin "of the Ministry of Health of the Russian Federation
Moscow, Russia
Branch of Hadassah Medical LTD Limited Liability Company
Moscow, Russia
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Moscow, Russia
Joint Stock Company "K31 City"
Moscow, Russia
JSC "Medsi Group"
Moscow, Russia
Moscow City Oncology Hospital No. 62
Moscow, Russia
State budgetary health care institution of the city of Moscow "City Clinical Oncology Hospital No. 1 of the Department of Health of the City of Moscow"
Moscow, Russia
Nizhny Novgorod Region State Budgetary Healthcare Facility "Clinical Diagnostics Center"
Nizhny Novgorod, Russia
LLC "DobroMed"
Novosibirsk, Russia
State Budgetary Healthcare Institution "Novosibirsk Regional Clinical Oncology Center" of the Novosibirsk Region
Novosibirsk, Russia
Federal State Budgetary Institution "National Medical Research Center for Radiology" of the Ministry of Health of the Russian Federation
Obninsk, Russia
Budgetary healthcare institution of the Omsk region "Clinical oncological dispensary"
Omsk, Russia
JSC "Modern Medical Technologies"
Saint Petersburg, Russia
Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological)
Saint Petersburg, Russia
City Hospital #40, Kurortny district
Saint Petersburg, Russia
Federal State Budgetary Educational Institution of Higher Education "Saint Petersburg State University"
Saint Petersburg, Russia
Limited Liability Company "American Medical Clinic"
Saint Petersburg, Russia
Limited Liability Company "Oncological Research Center"
Saint Petersburg, Russia
Limited Liability Company "Strategic Medical Systems"
Saint Petersburg, Russia
N.N. Petrov National Medicine Research Center of oncology
Saint Petersburg, Russia
Private Medical Institution Evromedservis
Saint Petersburg, Russia
Federal State Educational Institution of Higher Professional Education "Mordovia State University N.P. Ogareva "
Saransk, Russia
State Health Care Institution "Volgograd Regional Clinical Oncology Dispensary № 1"
Volgograd, Russia
Clinical Oncologic Dispensary No. 1
Krasnodar, Krasnodar Kari, Russia
Clinical Oncologic Dispensary No. 2
Sochi, Krasnodar Territory, Russia
Regional Clinical Oncology Hospital
Yaroslavl, Yaroslavl Oblast, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.